Log in

goodpods headphones icon

To access all our features

Open the Goodpods app
Close icon
headphones
The Dime

The Dime

Bryan Fields & Kellan Finney

Bryan and Kellan are curious learners, who explore the creative strategies of entrepreneurs pioneering the cannabis industry, projected to reach a $100 billion valuation by 2023. Each week, we dive into guests' journeys, from CEOs of publicly traded giants and world-renowned scientists to underground legacy growers shaping the industry. Discover how they found their place in Cannabis, their original business plans, and the pivots and perseverance needed to navigate cannabis-specific challenges. Join us to uncover the crucial lessons learned from these diverse and rich entrepreneurial experiences in the cannabis world.
bookmark
Share icon

All episodes

Best episodes

Top 10 The Dime Episodes

Goodpods has curated a list of the 10 best The Dime episodes, ranked by the number of listens and likes each episode have garnered from our listeners. If you are listening to The Dime for the first time, there's no better place to start than with one of these standout episodes. If you are a fan of the show, vote for your favorite The Dime episode by adding your comments to the episode page.

Imagine this...... The sun is shining, you’re lounging on a beautiful beach in Thailand with your partner.

The kids are with their grandparents when a friendly resort worker approaches with a smile and offers you an edible.

Sounds like a dream of mine, or maybe just another social media fantasy, right?

Nope, this is reality in 2024.

Kanha is revolutionizing plant medicine with a global perspective, making cannabis edibles an experience to be enjoyed across the world.

This week, we sit down with Cameron Clarke to dive into:

  • Kanha’s innovative partnership with Thai beach resorts.
  • How close we are to personalized cannabis therapy.
  • Kanha’s product strategy for Europe and Asia."
  • and so much more

Main Topics Discussed:

  • (00:01:53) Origins of Kanha - Cameron's background in biotech and how he got into the cannabis industry
  • (00:03:33) Early product development - Starting with extraction, then moving into edibles and tinctures
  • (00:05:46) Consistency and quality focus - Ensuring accurate labeling and potency
  • (00:09:26) Addressing onset time with nanotechnology
  • (00:13:08) Extraction methods and their impact on end products
  • (00:15:47) R&D process and new product development
  • (00:18:23) Launching products in new states and managing expansion
  • (00:20:31) Challenges of operating in a state-by-state regulated market
  • (00:21:12)Kanha expansion into Thailand
  • (00:27:49) Personalized cannabis and the role of genetics/endocannabinoid system
  • (00:35:33) The future of cannabis in health and wellness

Guest Links

The KANHA Story

Our founders embarked on a journey to seek greater balance in their lives that took them from the Amazon rainforest, to the jungles of West Africa, to the ancient cultures of Asia, including transformational lessons from a respected spiritual guide in India.

This spiritual journey profoundly impacted them and taught them how people from different cultures have learned to live in harmony with the world and how plant based medicine like cannabis can lead to a life of optimal wellness.

KANHA reflects the way we see cannabis and its role in connecting the world around us, serving as a metaphor that expresses how cannabis offers a better life and a stronger community through your own personal journey to happiness. KANHA strives to lead you on a joyful journey with delicious, reliable edibles. As a leading edible brand in the nation, KANHA delivers delectable gummies in an incredible variety of dosages, effects and flavors — so that consumers can taste the bliss at every step of their journey.

We’re dedicated to carefully crafting our wide range of products using only all-natural ingredients and premium cannabis oil extracted from pesticide-free flower, resulting in a perfectly consistent, accurate and delicious dose every time.

Our Links

Bryan Fields on Twitter

Kellan Finney on Twitter

The Dime on Twitter

At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain

The Dime is a top 5% most shared global podcast

The Dime is a top 50 Cannabis Podcast

Sign up for our playbook here:

🎥 YouTube: The Dime

📸 Instagram: The Dime

bookmark
plus icon
share episode

What is Bank Secrecy, and why are cash-heavy businesses like cannabis dispensaries, casinos, and laundromats treated the same?

Did regulators understand that they forced cannabis businesses were once forced into "criminal" banking practices?

Banking is available to the cannabis industry, but what are the differences?

We discuss the complexities of navigating federal and state regulations, the impact of the SAFE(R) Banking Act, and the differences between state-chartered and federally-chartered banks in handling cannabis-related transactions. Sundie also discusses the challenges of credit card processing for cannabis businesses and the emerging issues around hemp derivatives. Get a firsthand look at the strategies behind vetting and managing risky clients and what the future holds as the cannabis industry matures and evolves. If you're interested in the intersection of finance, regulation, and cannabis, this episode is packed with valuable insights and industry expertise. Perfect for cannabis entrepreneurs, banking professionals, and anyone interested in understanding the rapidly changing landscape of cannabis finance.

We sit down with Sundie Seefried to discuss the following:

  • Explaining Bank Secrecy
  • Differences in Banking Hemp vs. Cannabis
  • Visa/MasterCard: What is needed?
  • And so much more

Topics and Timestamps

  • Sundie’s background and how she got into the cannabis banking space (00:00:46 - 00:01:49)
  • The challenges of banking cannabis businesses and the "criminal" practices they were forced into prior to Safe Harbor (00:01:49 - 00:03:55)
  • Navigating regulations and relationships with state/federal regulators to establish a compliant cannabis banking program (00:03:55 - 00:07:07)
  • Differences between state-chartered and federally-chartered banking institutions when it comes to cannabis (00:07:07 - 00:08:01)
  • The impact of the SAFE Banking Act and the limitations it may have (00:08:32 - 00:10:05)
  • Challenges with credit card processing and merchant services for cannabis businesses (00:10:16 - 00:11:33)

Guest Links

  • https://shfinancial.org/
  • https://www.linkedin.com/in/sundie-seefried-748194130/
  • https://www.linkedin.com/company/safeharbor-financial/

About Sundie Seefried:

Safe Harbor Financial is the brainchild of Sundie Seefried. A 35-year veteran of the credit union industry, in 2014, she saw that CRBs needed financial services and that Colorado communities would be safer if the new industry had access to banking solutions.

A 39-year credit union industry veteran, Seefried was the former CEO of Partner Colorado Credit Union (PCCU). Established in 2015 by PCCU, Safe Harbor was formed to provide an unmet need – compliant banking and financial services to the rapidly growing U.S. cannabis industry. Seefried designed a full scope Cannabis Banking Program for PCCU known as the Safe Harbor program, which has withstood the scrutiny of 16 federal and state exams to date. Now in its 8th year, Safe Harbor has grown to nearly 600 accounts spanning 20 states, and processed over $12 billion in cannabis-related transactions.

Seefried regularly provides cannabis banking education and expertise to legislators, regulators, attorneys generals, state officials, and financial institutions. She is on a mission to normalize banking for the cannabis industry, while assisting law enforcement and federal agencies to be more effective at combating illicit activities and protecting the financial system.

To share her knowledge, Seefried authored the book ‘Navigating Safe Harbor – Cannabis Banking in Uncertain Times’ in 2016, as well as contributed a chapter on cannabis banking in the university textbook ‘The Politics of Marijuana: A New Paradigm’ by Timothy McGettigan.

Follow us: Our Links.

At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain

The Dime is a top 5% most shared global podcast

The Dime is a top 50 Cannabis Podcast

Sign up for our playbook here:

🎥 YouTube: The Dime

📸 Instagram: The Dime

bookmark
plus icon
share episode

Is Cannabis the most overlooked treatment in modern healthcare?

Learn how it could revolutionize care for cancer and other illnesses.

In this episode of The Dime, Dr. Benjamin Caplan, founder of CED Clinic and author of the "Doctor Approved Cannabis Handbook," joins us to discuss the untapped potential of Cannabis in medicine. From his journey as a traditional primary care doctor to becoming a leader in cannabis healthcare, Dr. Caplan dives deep into the science behind cannabis' therapeutic effects on conditions like cancer, Parkinson's, and even dementia. He challenges the misconceptions around Cannabis, discusses its impact on the endocannabinoid system, and explains why it could be the "Swiss army knife" of medicine. Tune in to learn about the real benefits of Cannabis, the gaps in medical education, and what it will take for the healthcare industry to embrace this powerful plant. Whether you're a patient, a healthcare professional, or just curious about Cannabis, this episode is packed with groundbreaking insights!

This week, we sit down with Dr. Benjamin Caplan to discuss the following:

  • The Overlooked Potential of Cannabis
  • Breakthroughs Not Widely Reported
  • Patient-Centric Cannabis Use
  • And so much more

Main Topics Discussed:

  • Dr. Caplan's background and how he got interested in cannabis (00:00:11 - 00:02:27)
  • The evolving public perception and acceptance of cannabis over time (00:02:27 - 00:07:46)
  • The endocannabinoid system and how cannabis interacts with the body (00:07:50 - 00:16:16)
  • Specific conditions and symptoms Dr. Caplan has seen cannabis help, including pain, anxiety, depression, sleep issues, and cancer (00:16:19 - 00:27:36)
  • The potential benefits of cannabis for skin health and as a natural sunscreen (00:36:24 - 00:38:51)
  • Dr. Caplan's views on recreational cannabis use (00:42:23 - 00:43:53)
  • Key insights and surprises from Dr. Caplan's "Doctor Approved Cannabis Handbook" (00:44:06 - 00:46:02)
  • Dr. Caplan's interest in studying cannabis and aging/the endocannabinoid system in older adults (00:46:02 - 00:47:03)

About Dr. Benjamin Caplan

Dr. Benjamin Caplan, a trailblazer in Medical Cannabis care, has spent over two decades integrating rigorous, evidence-based practices into his specialty clinic.

Recognized as one of the top 100 influential figures in cannabis, his work encompasses both patient care and groundbreaking clinical research.

As Principal Investigator in numerous studies and a contributor to prestigious journals like The New England Journal of Medicine, Dr. Caplan continues to explore the therapeutic benefits of medical cannabis. He is the founder and CMO of CED Clinic and EO Care, Inc., leading organizations in patient care and digital cannabis education. CED Clinic, a top medical cannabis clinic in Massachusetts for adults and children, boasts an impressive record of treating about 18,000 patients, and the supervision of nearly 300,000 others, with an expanding international reach. EO Care, a digital health company, offers HIPAA-compliant, data-driven cannabinoid treatments with clinical oversight. Additionally, Dr. Caplan established Solo* Sciences, a cannabis tech company, which was acquired by Akerna in 2020, marking a significant milestone in the industry. In 2023, Penguin Random House launched Dr Caplan’s "The Doctor-Approved Cannabis Handbook," to an international audience, sharing a comprehensive and accessible guide to cannabis therapies, supported by peer-reviewed references.

healthcare industry to embrace this powerful plant. Whether you're a patient, a healthcare professional, or just curious about cannabis, this episode is packed with groundbreaking insights!

Guest Links

  • https://benjamincaplan.com/
  • https://www.instagram.com/drbenjamincaplan/
  • https://doctorapprovedcannabishandbook.com/

Our Links

Bryan Fields on Twitter

Kellan Finney on Twitter

The Dime on Twitter

At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain

The Dime is a top 5% most shared global podcast

The Dime is a top 50 Cannabis Podcast

bookmark
plus icon
share episode

Flavors, terpenes, and genetics—all essential components of an incredible cannabis product. But how do you achieve this while running a vertically integrated business with volatile wholesale prices?

That’s the beauty of the cannabis industry: you're building the plane while flying it.

In this episode, the founders of Trade Roots reveal the secrets behind their exceptional strains and flavors.

Discover how they've mastered the art of transitioning from legacy to legal cannabis cultivation, integrating West Coast genetics with cutting-edge techniques. They also discuss how vertical integration gives them a unique edge in delivering top-tier products that stand out in the market.

This week, we sit down with the Carl Giannone & Jesse Pitts to discuss:

  • West Coast Genetics
  • Understanding Vertical Integration
  • Terpenes, THC & Consumer Education
  • And so much more

Key Topics Discussed

  • Jesse's background in the legacy cannabis market and transition to the legal industry (00:01:43)
  • Carl's perspective shift from viewing cannabis as a "business for criminals and children" to becoming a partner in Trade Roots (00:07:18)
  • The process of building Trade Roots' business plan, navigating regulations, and securing funding (00:13:08)
  • Vertical integration and the importance of maintaining control over the supply chain (00:17:21)
  • Challenges around testing, transparency, and integrity in the cannabis industry (00:38:57)
  • Bringing in West Coast genetics and balancing customer demand with commercial viability (00:50:53)
  • Highlights of Trade Roots' cultivation and extraction capabilities (00:59:29)

About Trade Roots

Trade Roots brings cannabis culture to the gateway of Cape Cod—Wareham, Massachusetts. We deliver a highly curated cannabis experience and have taken special care to tailor everything from our high-quality product to our gorgeous retail space to ensure a first-class experience for our customers.

Roots are important to us, and we’re proud of ours. One of our owners was born and raised in Wareham while the other lives in town, we’re staffed by members of the local community, our product is grown and produced on-site, and our retail shop features the work of local artists and craftsmen. As the saying goes, strong roots produce beautiful leaves.

Guest Links

Bryan Fields on Twitter

Kellan Finney on Twitter

The Dime on Twitter

At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain

The Dime is a top 5% most shared global podcast

The Dime is a top 50 Cannabis Podcast

Sign up for our playbook here:

🎥 YouTube: The Dime

📸 Instagram: The Dime

bookmark
plus icon
share episode

Humbling... How many times have we thought catalysts were on the way, only to find out at the last minute it was just a pawn or a negotiation tactic?

The question remains for optimists like myself: Is the thesis still intact? Yes, but the timing was off. A hard lesson learned—never count on DC for simple, sound decisions on a reasonable timeline.

Let’s revisit the thesis.

Gone are the days of unicorns, but we’re now in a phase where challenges persist, and change could come quickly. Optimist Bryan is still holding on.

How do you balance emotional attachment with a clear perspective on the investment thesis, recognizing these businesses are moving in the right direction and poised to explode?

This week, we sat down with Jesse Redmond to revisit this thesis and explore exactly that.

  • Cannabis Investing: A Generational Opportunity?
  • Pick & Shovel Strategies vs. MSOs in Cannabis
  • Balancing Political Catalysts and Investment Approach

Topics Discussed:

Jesse's background and path into the cannabis industry (00:02:05)

The current state of the cannabis investment thesis and opportunities ahead (00:06:18)

The potential impact of catalysts like Florida going adult-use and Schedule 3 rescheduling (00:09:37)

The relationship and dynamics between the cannabis and hemp industries (00:18:57)

Strategies for investing in the cannabis space, including ETFs and specialized companies (00:22:03)

The importance of understanding the "why" behind being involved in the cannabis industry (00:59:55)

Jesse's predictions for the next 12 months in the cannabis market (01:04:14)

About Jesse Redmond is the Managing Director at Water Tower Research where I cover cannabis and natural products. Before this, I founded two hedge funds and a leading California cannabis collective. I began my career at Franklin Templeton, was an early employee of Fisher Investments, and spent a decade co-managing multiple hedge funds. In this role, I allocated more than $1 billion to hedge fund strategies and conducted more than 1,000 due diligence visits around the world.
In 2016, I founded a dispensary outside of Santa Barbara, California, that became number one in its region. In 2020, I founded Higher Calling Consulting, where he helped investors find the best cannabis investments. Through these experiences, I bring a unique perspective to the sectors I cover.
In addition to publishing written research, I'm the co-host of The Water Tower Hour and Higher Exchanges podcasts.

Guest Links

Our Links

Bryan Fields on Twitter

Kellan Finney on Twitter

The Dime on Twitter

At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain

The Dime is a top 5% most shared global podcast

The Dime has a New Website. Shhhh its not finished.

The Dime is a top 50 Cannabis Podcast

Sign up for our playbook here:

🎥 YouTube: The Dime

📸 Instagram: The Dime

bookmark
plus icon
share episode

Research continues to show alcohol is harmful. If only a substitute social tonic could provide that happy feeling without the hangovers.

This week on The Dime, we host Luke Anderson, Co-Founder at Cann, to discuss:

  • Crossfading: Mixing of Alcohol & Cannabis.
  • Why Altering Framework Unlocks Beverage Category
  • Misconceptions on Beverage Market Size

About Cann:

Cann is a sessionable drink, meaning you can control and build your buzz because it's microdosed with just the right amount of THC. With a typical onset of just 10-15 minutes, start with one and go from there. For those new(ish) to cannabis, we typically recommended 1-2 Canns.

About Luke Anderson:

Luke Anderson is the co-founder of Cann, the world's first micro-dose THC beverage. With his colleague Jake Bullock, Anderson launched Cann in 2019, disrupting the industry with a sessionable cannabis-infused beverage line.

Guest Links:

  • https://drinkcann.com/
  • https://www.linkedin.com/company/drinkcann/
  • https://twitter.com/drinkcann

#cannabis-infusedbeverage #cannabisindustry #drinkcann

Follow us: Our Links.

At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain

The Dime is a top 5% most shared global podcast

The Dime is a top 50 Cannabis Podcast

Sign up for our playbook here:

🎥 YouTube: The Dime

📸 Instagram: The Dime

🐣 Twitter: Bryan Fields, Kellan Finney

🎙 The Dime Podcast:

bookmark
plus icon
share episode

Verano's portfolio encompasses 14 U.S. States, with active operations in 13, which includes 14 production facilities comprising over 1,000,000 square feet of cultivation.

This week on The Dime, we host Aaron Miles, CIO of Verano to discuss:

  • Investment differences between organic and M&A license acquisition
  • Building a national brand portfolio
  • Balancing capital investments in markets ahead of adult use
  • and so much more

About Verano:

Verano is a leading, vertically integrated, multi-state cannabis operator in the U.S., devoted to the ongoing improvement of communal wellness by providing responsible access to regulated cannabis products. With a mission to address vital health and wellness needs, Verano produces a comprehensive suite of premium, innovative cannabis products sold under its trusted portfolio of consumer brands, including VeranoTM, AvexiaTM, BITSTM, EncoreTM, MŪVTM and SavvyTM. Verano’s portfolio encompasses 14 U.S. states, with active operations in 13, including 14 production facilities comprising over 1,000,000 square feet of cultivation capacity. Verano designs, builds, and operates dispensaries under retail brands including Zen LeafTM and MŪVTM, delivering a superior cannabis shopping experience in both medical and adult use markets.

Verano Links

https://investors.verano.com/overview/default.aspx
https://www.verano.com/
https://twitter.com/veranobrands
https://www.facebook.com/veranobrands
https://www.instagram.com/veranobrands/?fbclid=IwAR0EqjU0SQodGxgPuSDgyrQUh8E1OqVwmug5KX3xm7FHPuwuUdmOYl427C4
https://www.linkedin.com/in/aaron-miles/
https://twitter.com/_aaronmiles_?lang=en

VRNOF (OTCMKTS)

#VRNOF #Cannabisinsider #cannabis

Follow us: Our Links.

At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain

The Dime is a top 5% most shared global podcast

The Dime is a top 50 Cannabis Podcast

Sign up for our playbook here:

🎥 YouTube: The Dime

📸 Instagram: The Dime

🐣 Twitter: Bryan Fields, Kellan Finney

🎙 The Dime Podcast:

bookmark
plus icon
share episode

This week we are joined by Brady Cobb, Founder of Sunburn, to discuss:

  • Florida Cannabis Market
  • The Why behind Sunburn
  • Publix effect
  • Sunburn vs. Trulieve?

About Brady Cobb: Brady Cobb is the founder and former CEO of Bluma Wellness, which was recently acquired by Cresco Labs. He founded One Plant Florida in 2018, a boutique-style medical marijuana company and that holds one of the fourteen medical marijuana treatment center licenses in the State of Florida. Cobb is a lawyer, entrepreneur and advocate for cannabis reform in Washington, DC, where he works with lobbyists and representatives to better the state of the industry through law.

#Cannabis #Cannabiscommunity #DEA

At Eighth Revolution (8th Rev) we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain

The Dime is a top 50 Cannabis Podcast

Contact us directly at [email protected] Bryan Fields: @bryanfields24 Kellan Finney: @Kellan_Finney

bookmark
plus icon
share episode
The Dime - Global Cannabis Politics ft. Nathan Mison
play

03/24/22 • 59 min

This week we are breaking down behind the scenes look at when Canada legalized Cannabis and the forward look to global trade negotiations.

We discuss:

  • How Canadians legalization violated international treaties
  • Why Consumption Lounges could be a massive opportunity
  • How future global regulations might not include the United States

About Nathan Mison:

Nathan Mison is a Founding Partner of Diplomat Consulting. As the former Vice President of Government and Stakeholder Relations at Fire & Flower, he was one of the first employees for the company, helping guide it through legalization and into its place as Canada’s largest independent cannabis retail company. Nathan is the co-chair of the National Cannabis Working Group for the Canadian Chamber of Commerce, a board member of the Alberta Cannabis Council. founding member of NorthCanvas, an ancillary cannabis incubator, a member of the Alberta Cannabis Stakeholder Group and a founding member of the Alberta Cannabis Retailers Association. He has a BA in Political Science and Philosophy from the University of Alberta and has volunteered his time as the Past President of the Valley Zoo Development Society and is the co-founder of Politics on Tap.

This show is presented to by 8th Revolution:

At Eighth Revolution (8th Rev) we provide services from capital to cannabinoid and everything in between in regard to the hemp & cannabis industry. Our forward-thinking team can diagnose, analyze & optimize every detailed nuance of your company to keep your business safe, smart, and profitable. Our flexibility and experience combined with ongoing research create unique insights into how to best grow your market share. Contact us directly at [email protected]

Bryan Fields: @bryanfields24

Kellan Finney: @Kellan_Finney

bookmark
plus icon
share episode

Cannabis reform always feels like it's on the verge of a breakthrough with policy.

We know some policies can pass both the House & Senate yet it doesn’t , but it ends up feeling like a pawn in the horse trading by policymakers who all know that ~70% of Americans are in favor of cannabis legalization. So why does policy that has support from both sides of the aisle struggle to make progress?

This week, we sit down with Erin Moffet and David Mangone to discuss:

  • Stories from Inside DC
  • Measuring Progress
  • Process of educating Member/Staffers
  • And so much more

About The Liaison Group

The Liaison Group (TLG) is a DC-based federal lobbying firm dedicated to shaping the federal legislative and policy landscape for the Cannabis Industry. TLG focuses its efforts and expertise in both the House and Senate with the overarching goal of protecting and preserving state-authorized Cannabis programs.

Key Topics Discussed:

  • David and Erin's background getting into cannabis lobbying (00:01:04)
  • What lobbying is and how it works in the cannabis industry (00:02:34)
  • Balancing relationships with members of Congress and educating them on cannabis (00:07:12)
  • Coordinating with other industry groups and finding the right messengers (00:13:18)
  • Navigating the complexities of cannabis policy and legislation (00:20:27)
  • Measuring success and the importance of the upcoming 6 months (00:42:54)

Follow us: Our Links.

Bryan Fields on Twitter

Kellan Finney on Twitter

The Dime on Twitter

At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain

The Dime is a top 5% most shared global podcast

The Dime is a top 50 Cannabis Podcast

Sign up for our playbook here:

🎥 YouTube: The Dime

📸 Instagram: The Dime

bookmark
plus icon
share episode

Show more best episodes

Toggle view more icon

FAQ

How many episodes does The Dime have?

The Dime currently has 224 episodes available.

What topics does The Dime cover?

The podcast is about Hemp, Cannabis Podcast, Management, Cannabis, Entrepreneurship, Podcasts, Science and Business.

What is the most popular episode on The Dime?

The episode title 'The Cannabis Industry is Exploding: Here's Why You Are Not Optimistic Enough ft Ben Burstein' is the most popular.

What is the average episode length on The Dime?

The average episode length on The Dime is 43 minutes.

How often are episodes of The Dime released?

Episodes of The Dime are typically released every 7 days.

When was the first episode of The Dime?

The first episode of The Dime was released on Nov 11, 2020.

Show more FAQ

Toggle view more icon

Comments